Dafalgan Grippal, Granulat zur Herstellung einer Lösung zum Einnehmen

7680676910013 CH-67691 Granulat
Dafalgan Grippal, Granulat zur Herstellung einer Lösung zum Einnehmen
Fiches Amavita / Sun Store / Coop Vitality

Article details

Package size
12
Selling units
12
Measure
Beutel
Galenic form
Granulat
Galenic group
Lösbar zur Einnahme

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
22/11/2025
Patient information leaflet
Français
22/11/2025
Patient information leaflet
Italien
22/11/2025
Summary of Product Characteristics
Allemand
22/11/2025
Summary of Product Characteristics
Français
22/11/2025
Summary of Product Characteristics
Italien
22/11/2025

Detailed composition

Substance Quantity Type Category
paracetamolum
500.0 MG Substance Wirkstoff (Principe actif)
acidum ascorbicum
200.0 MG Substance Wirkstoff (Principe actif)
pheniramini maleas
25.0 MG Substance Wirkstoff (Principe actif)
saccharum
7.555 G Substance HBESI
acidum citricum
- Substance HNIDK
saccharinum natricum
- Substance AIMDK
aromatica
- Substance AROMA
glucosum
195.0 MG Substance HBESI
fructosum
5.0 MG Substance HBESI
ethanolum
7.0 MG Substance HBESI
natrium
2.49 MG Substance HBESI

Authorization holder

UPSA Switzerland AG

6300 Zug

Authorization information

Swissmedic authorization number
67691
Drug name
Dafalgan Grippal, Granulat zur Herstellung einer Lösung zum Einnehmen
Galenic form
GRAL
ATC Code
N02BE51
Authorization status
Z
Dispensing category
D
First authorization
04/02/2021
Authorization expiration date
31/12/9999
IT Number
01.01.2.
Domain
Human medicine
Field of application
Symptomatische Behandlung bei Erkältungskrankheiten

Package details

Description (FR)
DAFALGAN GRIPPAL gran sachets 12 pce
Description (DE)
DAFALGAN GRIPPAL Gran Beutel 12 Stk
Market launch
04/02/2021
Narcotic (BTM)
No

Other package sizes (1)

DAFALGAN Grippal sache 500 mg 1 pce
1 BEU
GTIN: 7680676910020
Not in V1
Buy us a coffee Explore the data